Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis

Eric Yi‐Hsiu Huang(National Yang Ming Chiao Tung University), James Kennedy(Centre for Addiction and Mental Health), Amanda Lisoway(Centre for Addiction and Mental Health), Harpreet Kaur(Cleveland Clinic Lerner College of Medicine), Jerzy Samochowiec(Pomeranian Medical University), Felipe Ortuño(Centre for Addiction and Mental Health), Benedicto Crespo‐Facorro(Centro de Investigación Biomédica en Red de Salud Mental), Jeffrey R. Bishop(Centre for Addiction and Mental Health), Clement C. Zai(Centre for Addiction and Mental Health), Steven G. Potkin(University of California, Irvine), Małgorzata Maciukiewicz(Centre for Addiction and Mental Health), Patricio Molero(Clinica Universidad de Navarra), Herbert Y. Meltzer(Northwestern University), Daniel Felsky(Centre for Addiction and Mental Health), Jeffrey A. Lieberman(Unknown), Arun K. Tiwari(Centre for Addiction and Mental Health), Masashi Ikeda(Fujita Health University), Stefano Porcelli(Centre for Addiction and Mental Health), Shugui Gao(Centre for Addiction and Mental Health), Ritushree Kukreti(Centre for Addiction and Mental Health), José María Pelayo‐Terán(Universidad de Cantabria), Daniel J. Müller(University of Toronto), Paweł Mierzejewski(Centre for Addiction and Mental Health)
The International Journal of Neuropsychopharmacology
January 8, 2016
Cited by 64


Related Papers